These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 7016410)

  • 61. [Ergometric evaluation of sublingual nifedipine in angina patients. Double-blind cross-over study compared with a placebo].
    Ferrero JA; Llacer A; García-Fuster MJ; Chorro FJ; Insa LD; Merino J; Llopis R; López-Merino V
    Rev Esp Cardiol; 1980; 33(6):581-8. PubMed ID: 7010477
    [No Abstract]   [Full Text] [Related]  

  • 62. [Treatment of hypertensive emergencies with nifedipine].
    Mazza F; Messore T; Corvino A; Mercone G; Latte S; Giuffrida G
    Minerva Cardioangiol; 1982 Mar; 30(3):89-93. PubMed ID: 7088297
    [No Abstract]   [Full Text] [Related]  

  • 63. A comparison of chlorthalidone-reserpine and hydrochlorothiazide-methyldopa as step 2 therapy for hypertension.
    Channick BJ; Kessler WB; Marks AD; Adlin EV
    Clin Ther; 1981; 4(3):175-83. PubMed ID: 7307035
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Clinical evaluation of the effect of verapamil in hypertensive patients].
    Gelman A; de Albuquerque EM; Reynaldo Stella S; Draibe SA; Ajzen H
    Arq Bras Cardiol; 1983 Jan; 40(1):69-71. PubMed ID: 6351814
    [No Abstract]   [Full Text] [Related]  

  • 65. A randomised crossover comparison of reserpine and sustained-release nifedipine in hypertension.
    Manyemba J
    Cent Afr J Med; 1997 Dec; 43(12):344-9. PubMed ID: 9631111
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Combined evaluation of the therapeutic activity of nifedipine in coronary insufficiency alone and with hypertension].
    Di Marco G; De Simone G; Cionci M; Patriarchi F; Spadano E
    Boll Soc Ital Cardiol; 1980; 25(3):231-44. PubMed ID: 7284128
    [No Abstract]   [Full Text] [Related]  

  • 67. [Effects of a nifedipine-acebutolol combination in the treatment of patients with essential arterial hypertension].
    Strano A; Novo S; Licata G; Salerno L; Pinto A; Favi G; Botindari G
    Rev Esp Cardiol; 1982; 35(5 Suppl 2):II13-8. PubMed ID: 7170403
    [No Abstract]   [Full Text] [Related]  

  • 68. [Clinical experimentation with Hygroton-reserpine (apropos of 58 cases)].
    Warembourg H; Delomez M
    Lille Med; 1966 Jan; 11(1):72-5. PubMed ID: 5903756
    [No Abstract]   [Full Text] [Related]  

  • 69. Double-blind crossover study of once daily nifedipine coat core in essential hypertension.
    Missouris CG; Cappuccio FP; Markandu ND; Singer DR; MacGregor GA
    J Hum Hypertens; 1994 Apr; 8(4):289-92. PubMed ID: 8021910
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Comparison using the double-blind method of the hypotensive action of indapamide and that of another salidiuretic agent, chlorthalidone].
    Maus Y; Rorive G
    Rev Med Liege; 1978 May; 33(10):365-8. PubMed ID: 349655
    [No Abstract]   [Full Text] [Related]  

  • 71. [A new association for the treatment of essential arterial hypertension: G 37,736 (hygroton-reserpine)].
    Eisenberg R
    Sem Ther; 1965 Nov; 41(9):525-31. PubMed ID: 5877609
    [No Abstract]   [Full Text] [Related]  

  • 72. [Nifedipine in the treatment of hypertensive crises].
    Marlettini MG; Labriola E; De Novellis M; Lenzi T; Salomone T; Trisolino G; Di Battista N; Albini U; Pangia A
    Boll Soc Ital Cardiol; 1978; 23(9):1477-84. PubMed ID: 553622
    [No Abstract]   [Full Text] [Related]  

  • 73. [Treatment of hypertensive crisis with nifedipine].
    Padula R; Del Castillo D
    Boll Soc Ital Cardiol; 1981; 26(12):2385-94. PubMed ID: 7185410
    [No Abstract]   [Full Text] [Related]  

  • 74. Clinical trail with clonidine hydrochloride.
    Sunawala JD; Noronha JL; Gadgil UG; Pinto IJ
    J Assoc Physicians India; 1976 Jul; 24(7):423-7. PubMed ID: 1025120
    [No Abstract]   [Full Text] [Related]  

  • 75. Bisoprolol vs. chlorthalidone: a randomized, double-blind, comparative study in arterial hypertension.
    Bueno J; Amiguet JA; Carasusan J; Cebollada J; Carretero J
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S189-92. PubMed ID: 11527126
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Influence of nifedipine on the response to exercise in hypertensive patients].
    Giusti C; Mosti G; Tomei G; Galetta F
    Boll Soc Ital Cardiol; 1978; 23(10):1767-72. PubMed ID: 261839
    [No Abstract]   [Full Text] [Related]  

  • 77. [Evaluation of hemodynamic parameters after administration of nifedipine in hypertensive patients].
    Varricchio M; Cacciapuoti F; Russo R; Giunta R; Verza M; Grandillo F
    Minerva Cardioangiol; 1980; 28(1-2):59-68. PubMed ID: 7366854
    [No Abstract]   [Full Text] [Related]  

  • 78. The clinical effect of 4-(2'-nitrophenyl)2,6-dimethyl-3,5-dicarbomethoxy-1,4-dihydropyridine (BAY a 1040) on angina pectoris evaluated by sequential analysis.
    Kimura E; Mabuchi G; Kikuchi H
    Br J Clin Pract Suppl; 1980; 8():39-42. PubMed ID: 6781516
    [No Abstract]   [Full Text] [Related]  

  • 79. Double-blind comparison of dihydralazine and prazosin in hypertensive patients on the diuretic-reserpine regimen.
    Salmela PI; Jounela AJ; Karppanen H
    Ann Clin Res; 1981 Dec; 13(6):433-8. PubMed ID: 6753709
    [No Abstract]   [Full Text] [Related]  

  • 80. Effects of nifedipine, acebutolol, and their association on exercise tolerance in patients with effort angina.
    De Ponti C; De Biase AM; Pirelli S; Cataldo G; Salvadé P; Lanocita M; Carù B
    Cardiology; 1981; 68 Suppl 2():195-9. PubMed ID: 7032697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.